文献速递腹部MR

钆塞酸二钠增强MRI肝胆期联合扩散加权成像对神经内分泌肿瘤肝转移的检出与定性高度准确

The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
PubMed 文献 · Eur Radiol · 2020-06-29

本研究纳入67例疑似神经内分泌肿瘤肝转移患者,行钆塞酸增强MRI,3名放射科医师独立判读DWI、T2W+动态、T2WI+HBP、DWI+HBP四组图像。共识别625个病灶(545个转移灶、80个良性病灶),DWI+HBP组合检出率显著高于其他组(敏感度86%,特异度94%)。作者认为疑似肝转移的NET患者应考虑钆塞酸增强MRI,T2WI、DWI与HBP快速方案值得关注。

要点

  • DWI+HBP组合检出神经内分泌肿瘤肝转移的敏感度86%、特异度94%,高于其他图像组合。
  • HBP两组图像阅片者间一致性较高:T2WI+HBP的ICC为0.96,DWI+HBP的ICC为0.91。
  • 高ADC值、较大病灶及富血供模式可降低病灶被漏判为阴性的风险。

核心结论

  • DWI+HBP组合诊断准确度高,疑似神经内分泌肿瘤肝转移患者应考虑行钆塞酸增强MRI。
  • 采用T2WI、DWI和HBP的快速MRI方案在该人群中值得关注。

研究设计与样本

  • 比较动态增强期、肝胆期与DWI对神经内分泌肿瘤肝转移检出诊断准确度的研究。
  • 共纳入67例疑似神经内分泌肿瘤肝转移患者,均行钆塞酸增强MRI。
  • 3名放射科医师分别独立判读DWI、T2W+动态、T2WI+HBP、DWI+HBP四组图像。
  • 参考标准包括全部影像学、组织学结果和临床资料。

关键影像表现/征象

  • 共识别625个病灶,其中545个为转移灶、80个为良性病灶。

诊断标准与关键数值

  • DWI+HBP组合敏感度86%(95%CI 0.845-0.878)、特异度94%(95%CI 0.901-0.961)。
  • DWI单独敏感度82%、特异度65%;T2WI敏感度88%、特异度69%;HBP+T2WI敏感度90%、特异度82%。
  • 阅片者间一致性:T2WI+HBP的ICC为0.96(95%CI 0.94-0.97),DWI+HBP的ICC为0.91(95%CI 0.87-0.94),DWI的ICC为0.76(95%CI 0.66-0.83),T2+动态的ICC为0.85(95%CI 0.79-0.9)。
  • 高ADC值、大病灶及富血供模式与假阴性风险降低相关。

临床应用与阅片要点

  • 阅片时联合DWI与肝胆期图像可提高神经内分泌肿瘤肝转移的检出敏感度和特异度。
  • HBP图像组合的阅片者间一致性较高,支持在报告中使用该组合。
  • 高ADC值、大病灶及富血供模式可能提示假阴性风险较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the diagnostic accuracy of dynamic contrast-enhanced phases, hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver metastases from neuroendocrine tumor (NET).

METHODS: Sixty-seven patients with suspected NET liver metastases underwent gadoxetic acid-enhanced MRI. Three radiologists read four imaging sets separately and independently: DWI, T2W+dynamic, T2WI+HBP, and DWI+HBP. Reference standard included all imaging, histological findings, and clinical data. Sensitivity and specificity were calculated and compared for each imaging set. Interreader agreement was evaluated by intraclass correlation coefficient (ICC). Univariate logistic regression was performed to evaluate lesion characteristics (size, ADC, and enhancing pattern) associated to false positive and negative lesions.

RESULTS: Six hundred twenty-five lesions (545 metastases, 80 benign lesions) were identified. Detection rate was significantly higher combining DWI+HBP than the other imaging sets (sensitivity 86% (95% confidence interval (CI) 0.845-0.878), specificity 94% (95% CI 0.901-0.961)). The sensitivity and specificity of the other sets were 82% and 65% for DWI, 88% and 69% for T2WI, and 90% and 82% for HBP+T2WI, respectively. The interreader agreement was statistically higher for both HBP sets (ICC = 0.96 (95% CI 0.94-0.97) for T2WI+HBP and ICC = 0.91 (95% CI 0.87-0.94) for DWI+HBP, respectively) compared with that for DWI (ICC = 0.76 (95% CI 0.66-0.83)) and T2+dynamic (ICC = 0.85 (95% CI 0.79-0.9)). High ADC values, large lesion size, and hypervascular pattern lowered the risk of false negative.

CONCLUSION: Given the high diagnostic accuracy of combining DWI+HBP, gadoxetic acid-enhanced MRI is to be considered in NET patients with suspected liver metastases. Fast MRI protocol using T2WI, DWI, and HBP is of interest in this population.

KEY POINTS: • The combined set of diffusion-weighted (DW) and hepatobiliary phase (HBP) images yields the highest sensitivity and specificity for neuroendocrine liver metastasis (NELM) detection. • Gadoxetic acid should be the contrast agent of choice for liver MRI in NET patients. • The combined set of HBP and DWI sequences could also be used as a tool of abbreviated MRI in follow-up or assessment of treatment such as somatostatin analogs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Hayoz R, Vietti-Violi N, Duran R, et al. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor. Eur Radiol. 2020. PMID: 32601948. doi:10.1007/s00330-020-06930-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。